Sio Capital Management »

Neumora Therapeutics shares owned by Sio Capital Management

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Sio Capital Management from 13F filings

Historical chart of Sio Capital Management investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Sio Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Sio Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $6.7M 636k 10.60

More positions owned by Sio Capital Management

Maximus (MMS)
Celcuity (CELC)
Sanofi Sa Sponsored Adr (SNY)
Dianthus Therapeutics (DNTH)
Alkermes SHS (ALKS)
Disc Medicine (IRON)
Merck & Co (MRK)
Henry Schein (HSIC)
Centene Corporation (CNC)
Kenvue (KVUE)
BioMarin Pharmaceutical (BMRN)
GSK Sponsored Adr (GSK)
Bright Minds Biosciences Com New (DRUG)
Haemonetics Corporation (HAE)
Aquestive Therapeutics (AQST)

View all positions for Sio Capital Management

Top funds holding Neumora Therapeutics

Softbank Group Corp
MIC Capital Management UK
Siren
Vanguard Group
FMR
Wellcome Trust Limited, as Trustee of the Wellcome Trust
ICONIQ Capital
Lunate Capital
Millennium Management
T. Rowe Price Investment Management
Johnson & Johnson
BlackRock
Tang Capital Management
Renaissance Technologies
Two Sigma Advisers

View all funds holding Neumora Therapeutics